Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
China Catalyst Holding Co., Ltd. (688267.SS)
Dalian, CN
Based in Dalian, China, China Catalyst Holding Co., Ltd., established in 2008, is actively engaged in the research, development, production, and global distribution of zeolite catalysts, tailored process solutions, and various fine chemicals. The company, formerly known as Dalian Heterogeneous Catalyst Co., Ltd. until its rebranding in November 2015, serves the environmental protection, energy, and chemical industries. Its extensive product portfolio includes specialized molecular sieves and a wide array of catalysts such as those used for hydrogen peroxide to propylene oxide (HPPO), epichlorohydrin (POCL), high-purity methanol, hydrogenation of dimethyl oxalate to ethylene glycol (DEG), ammoximation, pyridine, medical oxygen production (via zeolite adsorbents), and isomerization. Furthermore, China Catalyst supplies fine chemical compounds like tetrapropylammonium hydroxide, N,N,N-trimethyl-1-ammonium adamantine, and isopentenyl alcohol.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.77% | -4.13% | +8.81% | +9.46% | +21.95% | +17.93% | +28.02% | +40.52% | -21.28% | -21.28% | -21.28% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+28.4% ★ Q1'26: +17.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+38.8% ★ Q1'26: -21.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+28.1% ★ Q1'26: -11.9% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+28.3% ★ Q1'26: +17.0% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+14.2% ★ Q1'26: +7.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+3.1% Q1'26: -2.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.08× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
680.66M
est: 720.92M (-5.6%)
|
549.88M
est: 708.74M (-22.4%)
|
666.61M
est: 801.00M (-16.8%)
|
855.72M
est: 858.00M (-0.3%)
|
1.15B
1.15B – 1.15B
+33.9% YoY
|
1.33B
1.33B – 1.33B
+15.7% YoY
|
1.51B
1.51B – 1.51B
+13.5% YoY
|
| EBITDA |
246.54M
est: 256.20M (-3.8%)
|
162.54M
est: 253.66M (-35.9%)
|
242.19M
est: 286.68M (-15.5%)
|
319.87M
est: 307.08M (+4.2%)
|
411.19M
411.19M – 411.19M
+33.9% YoY
|
475.61M
475.61M – 475.61M
+15.7% YoY
|
540.03M
540.03M – 540.03M
+13.5% YoY
|
| EBIT |
178.92M
est: 178.09M (+0.5%)
|
88.83M
est: 176.02M (-49.5%)
|
164.33M
est: 198.94M (-17.4%)
|
242.01M
est: 213.09M (+13.6%)
|
285.34M
285.34M – 285.34M
+33.9% YoY
|
330.04M
330.04M – 330.04M
+15.7% YoY
|
374.75M
374.75M – 374.75M
+13.5% YoY
|
| Net Income |
151.81M
est: 160.51M (-5.4%)
|
76.91M
est: 136.58M (-43.7%)
|
145.52M
est: 167.68M (-13.2%)
|
204.85M
est: 204.75M (+0.0%)
|
245.35M
245.35M – 245.35M
+19.8% YoY
|
314.19M
314.19M – 314.19M
+28.1% YoY
|
367.14M
367.14M – 367.14M
+16.9% YoY
|
| SGA |
68.05M
est: 26.95M (+152.5%)
|
73.49M
est: 61.79M (+18.9%)
|
63.40M
est: 69.83M (-9.2%)
|
20.28M
est: 74.80M (-72.9%)
|
100.16M
100.16M – 100.16M
+33.9% YoY
|
115.85M
115.85M – 115.85M
+15.7% YoY
|
131.54M
131.54M – 131.54M
+13.5% YoY
|
| EPS |
0.90
est: 0.94 (-4.0%)
|
0.44
est: 0.77 (-43.1%)
|
0.85
est: 0.95 (-10.5%)
|
1.18
est: 1.16 (+1.7%)
|
1.39
1.39 – 1.39
+19.8% YoY
|
1.78
1.78 – 1.78
+28.1% YoY
|
2.08
2.08 – 2.08
+16.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-28 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-27 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-25 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Sophus Capital Emerging Market Small Cap ETF EMSC | 0.36% | 161.6K | 0.85% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Haitao Liu | Deputy General Manager | — | male |
| Hong Ying Sun | Project Leader | — | female |
| Li Hua Shi | Project Leader | — | female |
| Shan Jiang | Chief Engineer | — | male |
| Yuanling Huang | Financial Director | — | female |
| Yuke Zhen | GM & Director | — | male |
| Zhi Guang Wang | Vice Minister of R&D Department | — | male |
| Zhong Jin | Deputy GM, Secretary of the Board of Directors & Director | — | male |
| Zi Guo Wang | Accounting Supervisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 688267.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
